Havana, Cuba

Roberto Vera Alvarez

This inventor holds 2 USPTO granted patents and 3 EPO patents. Top assignees: Centro De Ingenieria Genetica Y Biotechnologia, Centro De Ingenieria Genetica Y Biotecnologia. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roberto Vera Alvarez. Retrieved from https://idiyas.com/inventor/roberto-vera-alvarez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 11(Granted Patents)


Location History:

  • La Habana, CU (2014)
  • Havana, CU (2014)

Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Roberto Vera Alvarez

Introduction

Roberto Vera Alvarez is a notable inventor based in La Habana, Cuba. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating serious diseases. With a total of 2 patents, his work reflects a commitment to advancing medical science.

Latest Patents

Alvarez's latest patents include innovative antineoplastic compounds and pharmaceutical compositions derived from in silico molecular modeling. These compounds are designed to block phosphorylation events through specific interactions with the Casein Kinase 2 enzyme substrate phosphorylation domain. This invention also encompasses pharmaceutical compositions that utilize these compounds for the treatment of diseases related to neoplastic processes. Another significant patent involves the use of chemical compounds obtained in silico to prepare pharmaceutical compositions that attenuate or inhibit Dengue virus infection. This invention targets various stages of the viral replication cycle, particularly focusing on the entry of the virus into host cells and the assembly of mature progeny virions. The pharmaceutical compositions developed can be used for both prophylactic and therapeutic treatment of infections caused by all four serotypes of the Dengue virus and other flaviviruses.

Career Highlights

Throughout his career, Alvarez has worked with esteemed institutions such as the Centro de Ingeniería Genética y Biotecnología. His work in these organizations has allowed him to contribute to groundbreaking research and development in the field of biotechnology and pharmaceuticals.

Collaborations

Alvarez has collaborated with notable colleagues, including Yuliet Mazola Reyes and Alexis Musacchio Lasa. These partnerships have further enriched his research and innovation efforts.

Conclusion

Roberto Vera Alvarez stands out as a significant figure in the realm of pharmaceutical innovation. His contributions through his patents demonstrate a dedication to improving health outcomes and addressing critical medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…